INmune Bio: Q4 Earnings Insights

+0.93%

INmune Bio Inc.

INMB

6.29

+0.93%

INmune Bio (NASDAQ:INMB) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

INmune Bio missed estimated earnings by -7.000000000000001%, reporting an EPS of $-0.47 versus an estimate of $-0.44.

Revenue was down $69 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.07 which was followed by a 4.0% drop in the share price the next day.

To track all earnings releases for INmune Bio visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.